Verona Pharma welcomes Non-Executive Director

Verona Pharma has appointed Martin Edwards to the board as a Non-Executive Director, effective from 1 April 2019, the company said Thursday.

Verona welcomed Dr. Edwards who has over three decades of experience in the pharmaceutical and venture capital industries, currently Senior Partner of Novo Holdings, where he has held various positions since 2003.

Novo Holdings has a shareholding of 11.76% in Verona Pharma, the company noted.

“Notwithstanding this, our Board of Directors considers Dr. Edwards to be an independent director under UK and US corporate governance rules,”it was said int he press release by the company.

Dr. David Ebsworth, Chairman of Verona Pharma, said: “We are delighted to welcome Martin to our Board. His substantial expertise in the sector, along with his unique leadership insights and perspective, will be valuable as we continue to advance ensifentrine into late-stage clinical development.”